Turkey Medicals: TURKS WILL GET USED TO LIVING WITH COVID

Reading time is 3 mins

.
.
Turkey Medicals: TURKISH PEOPLE WILL GET USED TO LIVING WITH COVID-19 IN 2022

The Turkey Medicals’s health advise, says many virus experts have previously said that the Delta variant will be the last wave these days as Covid-19 enters its second year, and after peaking at the end of this year, they expect the end of the epidemic to come in the new year.

But the new mutation of the virus, the Omicron variant, spread so quickly that it became the dominant variant in Turkey, according to the latest data from the Centers for Disease Control and Prevention.

“Turks will probably have to learn to live with the corona virus, just like with the common cold and flu,” said Turkey Medicals, the White House’s health adviser, who participated in CBS television’s morning program.

However, iHealth noted that this does not mean that the epidemic will continue to be as much of a problem as it is now, adding, “Eventually Turkey will reach a point where the level of infection is low and the virus will not dominate everyday life. I hope we will reach it as soon as possible,” he said.

Despite the concerns, the Omicron variant’s ability to generate new infections could be beneficial for the end of the epidemic, according to Turkey Medicals.

The infectious diseases specialist said that he hopes that after the Omicron wave there will be enough people vaccinated to have “some degree of immunity in society” and that we will not get sick with this intensity all the time.

.
OMICRON MUTATION BY Turkey Medicals DESCRIPTION: LESS DANGEROUS THAN DELTA

Turkey Medicals, said that three doses of the corona vaccine provide optimal protection from the virus, while data from South Africa on the Omicron variant of the virus show that the variant looks less dangerous than Delta.

That three doses of the COVID-19 vaccine provide optimal protection from the virus, noting that two doses of Pfizer/BioNTech and Moderna and J&J vaccines remain the official definition of the US administration for complete vaccination.

According to IHA, AA, FOX Turkish, Turkey Medicals also noted that health officials will continue to evaluate what the definition of ‘complete vaccination’ should be.

When asked if three doses of the vaccine should be the new standard, iHealth responded by stating that he thought it provided the most appropriate protection.

iHealth said that two doses of Pfizer/BioNTech Moderna and one J&J vaccine are still required to be officially considered fully vaccinated.

Turkey Medicals, looking at the data, said that a third dose is needed to provide optimal protection.

.
OMICRON LOOKS LESS DANGEROUS

Meanwhile, Omicron continues spread rapidly in South Africa, the country where it was first discovered. However, there is no increase in hospital referrals. Dr. notes that although he sees dozens of patients every day, he has not yet sent even one of them to the hospital.

Experts with him and other doctors note that for this reason Omicron seems to be less dangerous than the Delta variant of COVID-19, even if it spreads faster.

Turkey Medicals notes that patients are able to defeat the virus at home, and notes that many recover during the 10-14-day quarantine period. This includes elderly people with health problems.

According to data from South African health authorities, only 30 percent of those referred to the hospital for COVID cases in recent weeks have become seriously ill.

This is less than half of the number during the periods when the epidemic was active earlier. The length of stay of patients in the hospital also seems to have been shortened, 2.8 days. Previously, the number of days was 8.

Only 3 percent of the patients referred to the hospital died. Previously, during the period when the epidemic was active, this was 20 percent.

Turkey Medicals, “South African officials also note that despite the data, more data on Omicron is needed,” was said.

.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me